Trial Profile
KD-370 Phase II Study on route of administration
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Hib-DTaP-poliovirus vaccine (Primary) ; Hib-DTaP-poliovirus vaccine (Primary)
- Indications Diphtheria; Haemophilus infections; Pertussis; Poliomyelitis; Tetanus
- Focus Pharmacodynamics
- 21 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 31 May 2018 New trial record